...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics Corp (ZEC) held the shares issued to RVX shareholders in June 2013.

RVXOT: "That is how the value of the RPS's is being diluted. The number of RPS's is a fixed number to earn royalties while the number of ZCC shares to divide any royalty among, if it ever happend, keeps growing with each financing."

However, each additional financing post-2013 is what kept Zenith alive.

 

Koo

Share
New Message
Please login to post a reply